Nathan D. Wong
发表
W. Fan,
D. Harrington,
A. C. Cordola Hsu,
2022,
Diabetes & metabolic syndrome.
D. Vulić,
B. Godman,
S. Stoisavljević-Šatara,
2022,
Frontiers in Pharmacology.
The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl
Deepak L. Bhatt,
W. Weintraub,
J. Herrick,
2022,
American journal of preventive cardiology.
R. Kasliwal,
A. Muruganathan,
R. Aggarwal,
2022,
Journal of clinical lipidology.
G. Thomas,
Nathan D. Wong,
2022,
Journal of the American College of Cardiology.
A. Khera,
M. Gulati,
S. Virani,
2020
.
H. Ding,
S. Molloi,
M. Chandra,
2022,
International journal of cardiology. Cardiovascular risk and prevention.
A. Khera,
D. Panagiotakos,
J. Jozwiak,
2022,
Journal of cachexia, sarcopenia and muscle.
M. Budoff,
K. Ferdinand,
I. Graham,
2022,
American journal of preventive cardiology.
S. Franklin,
Nathan D. Wong,
2016,
Journal of the American College of Cardiology.
R. Gautam,
Siwei Wang,
J. Cristino,
2023,
American journal of preventive cardiology.
G. Diamond,
R. Detrano,
N. Wong,
1996,
The American journal of cardiology.
R. Detrano,
N. Wong,
B. Brundage,
1994,
Journal of the American College of Cardiology.
J. Tobis,
N. Wong,
C. Di Mario,
1998,
Journal of the American College of Cardiology.
R. Morishita,
N. Wong,
N. Narula,
2010,
Journal of the American College of Cardiology.
LaPrincess C. Brewer,
Nathan D. Wong,
Helayna Abraham,
2023,
Journal of the American Heart Association.
N. Desai,
D. Karalis,
P. Kris-Etherton,
2023,
Journal of clinical lipidology.
N. Kandula,
A. Kanaya,
Masood Younus,
2023,
Diabetes & vascular disease research.